Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.81 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.55 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | HRH1 | P35367 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10897254 | 0.94 | CA2 (0.81) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL8856847 | 0.93 | CA2 (0.71) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL27901184 | 0.92 | CA2 (0.77) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| Ammonia Solution, Strong SCHEMBL28267146 | 0.92 | CA2 (0.77) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL14359878 | 0.92 | CA2 (0.77) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL14360381 | 0.92 | CA2 (0.77) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL1509190 | 0.91 | CA2 (0.68) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL29755829 | 0.91 | CA2 (0.75) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL6698087 | 0.91 | CA2 (0.68) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL27797935 | 0.91 | CA2 (0.91) | CA2MAPK1CHRM1AKR1A1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117813295-A | Compounds targeting p53 mutants | 北京加科思新药研发有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3810615-A1 | ARGINASE INHIBITORS AND METHODS OF USE | Merck Sharp & Dohme Corp. (US) | 2021-04-28 | — | — | EP | disclosed |
| WO-2019245890-A1 | ARGINASE INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME CORP. (US) | 2019-12-26 | — | — | WO | disclosed |
| US-20170119910-A1 | ENZYMATICALLY RESPONSIVE MAGNETIC PARTICLES AND THEIR USE | BRANDEIS UNIVERSITY | 2017-05-04 | — | — | US | disclosed |
| US-9340691-B2 | Hot melt ink composition comprising a copolyester and process for preparing a copolyester | OCE-TECHNOLOGIES B.V. (NL) | 2016-05-17 | — | — | US | disclosed |
| EP-2596960-B1 | Reusable print medium and method of manufacturing thereof | OCE TECH BV (NL) | 2016-04-20 | — | — | EP | disclosed |
| US-8809432-B2 | Reusable print medium and method of manufacturing thereof | OCE TECHNOLOGIES B.V. (NL) | 2014-08-19 | — | — | US | disclosed |
| EP-2726564-A2 | HOT MELT INK COMPOSITION COMPRISING A COPOLYESTER AND PROCESS FOR PREPARING A COPOLYESTER | OCE-Technologies B.V. (NL) | 2014-05-07 | — | — | EP | disclosed |
| US-20140114013-A1 | HOT MELT INK COMPOSITION COMPRISING A COPOLYESTER AND PROCESS FOR PREPARING A COPOLYESTER | OCE-TECHNOLOGIES B.V. (NL) | 2014-04-24 | — | — | US | disclosed |
| US-20130137805-A1 | REUSABLE PRINT MEDIUM AND METHOD OF MANUFACTURING THEREOF | OCE TECHNOLOGIES B.V. (NL) | 2013-05-30 | — | — | US | disclosed |
| EP-2596960-A2 | Reusable print medium and method of manufacturing thereof | Océ-Technologies B.V. (NL) | 2013-05-29 | — | — | EP | disclosed |
| WO-2013018929-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-07 | — | — | WO | disclosed |
| WO-2013000761-A2 | HOT MELT INK COMPOSITION COMPRISING A COPOLYESTER AND PROCESS FOR PREPARING A COPOLYESTER | OCE-TECHNOLOGIES B.V. (NL) | 2013-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119910-A1 | ENZYMATICALLY RESPONSIVE MAGNETIC PARTICLES AND THEIR USE | DNPEP, ENPEP, ANPEP | CA2 1152/4885MAPK1 326/4885CHRM1 3830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.